TY - GEN AU - Rio-Vilariño, A. AU - Cenigaonandia-Campillo, A. AU - García-Bautista, A. AU - Mateos-Gómez, P.A. AU - Schlaepfer, M.I. AU - del Puerto-Nevado, L. AU - Aguilera, O. AU - García-García, L. AU - Galeano, C. AU - de Miguel, I. AU - Serrano-López, J. AU - Baños, N. AU - Fernández-Aceñero, M.J. AU - Lacal, J.C. AU - Medico, E. AU - García-Foncillas, J. AU - Cebrián, A. T1 - Correction to: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells (British Journal of Cancer, (2024), 130, 8, (1402-1413), 10.1038/s41416-024-02649-z) PY - 2024/05/03/ SP - 1414 T2 - British Journal of Cancer SN - 1532-1827 VL - 130 IS - 8 PB - Springer Nature AB - Correction to: British Journal of Cancerhttps://doi.org/10.1038/s41416-024-02649-z, published online 11 March 2024 In this article, the funding section needs be rephrased. Currently it reads: “This work was supported by the grant PI19/01231 funded by AEI and the European Union. A.R-V contract was funded by the program “CONTRATOS PREDOCTORALES DE FORMACIÓN EN INVESTIGACIÓN EN SALUD (PFIS)”, grant FI20/00213 from the Instituto de Salud Carlos III (ISC-III) and co-funded by the European Union associated with the project PI19/01231.” It should be updated to: “This work was supported by the grant PI19/01231 funded by AEI and the European Union. A.R-V contract was funded by the program “CONTRATOS PREDOCTORALES DE FORMACIÓN EN INVESTIGACIÓN EN SALUD (PFIS)”, grant FI20/00213 from the Instituto de Salud Carlos III (ISC-III) and co-funded by the European Union (ERDF/ESF, “A way to make Europe”/“Investing in your future”) associated with the project PI19/01231. The original article has been updated. DO - 10.1038/S41416-024-02667-X UR - https://portalcientifico.uah.es/documentos/6633a64f3eb1a152cbc0d6e5 DP - Dialnet - Portal de la Investigación ER -